MTHFR Part 7.2: Homocysteine continues…

“Homocysteine: Small Molecule, Big Impact”

 

 

Homocysteine is a sulfur-containing amino acid that the body can either convert into cystathionine (and then into cysteine) through the transsulfuration pathway or recycle back into methionine through remethylation.

The remethylation process occurs mainly in body tissues and is driven by the enzyme methionine synthase, which requires vitamin B12 (cobalamin) as a cofactor and folate (5-methyltetrahydrofolate) as the methyl donor.

In the liver and kidneys, there’s a second remethylation route that uses betaine (trimethylglycine) as the methyl donor. Choline is the direct precursor to betaine and plays multiple critical roles in the body, including:

  • Supporting cell membrane formation

  • Aiding in the production of acetylcholine, a key neurotransmitter

  • Playing a vital role in fetal development and neurological function

🧬 Homocysteine Imbalance: Too High or Too Low

Homocysteine levels that are either too high or too low can signal underlying metabolic issues. Here’s a breakdown of the two main conditions:

🔺 1. Hyperhomocysteinemia

This condition occurs when homocysteine levels in the blood exceed 15 μmol/L. It may involve both free homocysteine and bound forms like homocysteine-cysteine disulfide.

Common causes include:

  • Deficiencies in vitamin B6, B9 (folate), and B12

  • Genetic variants (e.g., MTHFR mutations)

  • Excessive methionine intake

  • Chronic illnesses and inflammatory conditions

Why it matters:
Hyperhomocysteinemia is a recognised risk factor for cardiovascular disease and may contribute to other health issues such as clotting disorders and neurological symptoms.

⚠️ 2. Homocystinuria

A rare but more severe genetic disorder, homocystinuria is an autosomal recessive condition marked by very high levels of homocysteine in both blood and urine.

Typical features include:

  • Developmental delays

  • Osteoporosis

  • Eye abnormalities (lens dislocation)

  • Blood clot risk (thromboembolism)

  • Early-onset cardiovascular disease (e.g., atherosclerosis)

This condition is usually diagnosed in childhood and requires medical management.

🔻 3. Hypohomocysteinemia (Low Homocysteine)

Although less common, low homocysteine levels can also be problematic.

Potential causes:

  • Increased demand for glutathione, pulling cysteine from homocysteine

  • Low intake of methionine or cysteine

  • Impaired MTHFR enzyme function

  • Low folate or B12 intake

  • Overactive Phase II liver detoxification (sulfation pathway)

  • Enhanced taurine synthesis from cysteine (stimulated by high fat or alcohol intake)

What it indicates:
Low homocysteine may reflect oxidative stress, as the body diverts resources to make more glutathione, a key antioxidant. It can also signal overactive detox pathways, like CBS upregulation, which pushes homocysteine into the transsulfuration pathway to produce cysteine and taurine.

💡 Clinical Insight:

  • In malnutrition-inflammation-cachexia syndrome, low methionine intake combined with elevated homocysteine levels can worsen chronic kidney disease and influence patient survival outcomes.

  • Low antioxidant status can increase the body’s need for glutathione, causing it to draw cysteine from homocysteine, further reducing its levels.

PLEASE NOTE: ANY VIEWS REGARDING THE RESULTS ARE MY UNDERSTANDING AND DO NOT SERVE AS PROFESSIONAL ADVICE. THE TREATMENT RECOMMENDATION IS STRICTLY RELATED TO ALEX’S RESULTS AND NOT MEANT FOR SELF-TREATMENT. ALWAYS SPEAK TO YOUR HEALTHCARE PROVIDER BEFORE STARTING ANY TREATMENTS.

Scroll to Top